Comerica Bank lifted its stake in LeMaitre Vascular Inc (NASDAQ:LMAT) by 53.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 35,795 shares of the medical instruments supplier’s stock after purchasing an additional 12,400 shares during the quarter. Comerica Bank’s holdings in LeMaitre Vascular were worth $1,234,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Teachers Retirement System of The State of Kentucky acquired a new stake in shares of LeMaitre Vascular in the second quarter valued at about $137,000. Victory Capital Management Inc. lifted its stake in shares of LeMaitre Vascular by 181.2% in the third quarter. Victory Capital Management Inc. now owns 4,139 shares of the medical instruments supplier’s stock valued at $155,000 after purchasing an additional 2,667 shares during the period. Royal Bank of Canada lifted its stake in shares of LeMaitre Vascular by 856.5% in the second quarter. Royal Bank of Canada now owns 5,031 shares of the medical instruments supplier’s stock valued at $157,000 after purchasing an additional 4,505 shares during the period. BB&T Corp acquired a new stake in shares of LeMaitre Vascular in the fourth quarter valued at about $202,000. Finally, Voya Investment Management LLC acquired a new stake in shares of LeMaitre Vascular in the second quarter valued at about $203,000. Hedge funds and other institutional investors own 75.04% of the company’s stock.
LeMaitre Vascular Inc (NASDAQ LMAT) opened at $35.66 on Tuesday. The stock has a market cap of $689.49, a PE ratio of 42.11, a price-to-earnings-growth ratio of 2.43 and a beta of 0.53. LeMaitre Vascular Inc has a 52-week low of $21.52 and a 52-week high of $39.88.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 5th. Shareholders of record on Thursday, March 22nd will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Wednesday, March 21st. This represents a $0.28 dividend on an annualized basis and a yield of 0.79%. This is a boost from LeMaitre Vascular’s previous quarterly dividend of $0.06. LeMaitre Vascular’s payout ratio is presently 25.88%.
Several analysts recently commented on LMAT shares. Zacks Investment Research upgraded shares of LeMaitre Vascular from a “hold” rating to a “buy” rating and set a $35.00 price objective for the company in a research note on Thursday, December 28th. BidaskClub upgraded shares of LeMaitre Vascular from a “strong sell” rating to a “sell” rating in a research note on Tuesday, January 16th. Finally, Canaccord Genuity reiterated a “hold” rating and issued a $33.00 price objective on shares of LeMaitre Vascular in a research note on Friday. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. LeMaitre Vascular has a consensus rating of “Hold” and a consensus target price of $33.00.
LeMaitre Vascular Company Profile
LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.
Want to see what other hedge funds are holding LMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LeMaitre Vascular Inc (NASDAQ:LMAT).
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.